Ocugen Inc (OCGN)
1.005
+0.05
(+4.88%)
USD |
NASDAQ |
Nov 14, 16:00
1.01
0.00 (0.00%)
After-Hours: 20:00
Ocugen Research and Development Expense (Quarterly): 8.902M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.902M |
| March 31, 2024 | 6.826M |
| December 31, 2023 | 9.504M |
| September 30, 2023 | 6.342M |
| June 30, 2023 | 14.57M |
| March 31, 2023 | 10.17M |
| December 31, 2022 | 23.62M |
| September 30, 2022 | 15.62M |
| June 30, 2022 | 9.007M |
| March 31, 2022 | 7.915M |
| December 31, 2021 | 7.102M |
| September 30, 2021 | 6.281M |
| June 30, 2021 | 18.85M |
| March 31, 2021 | 2.872M |
| December 31, 2020 | 1.594M |
| September 30, 2020 | 1.478M |
| June 30, 2020 | 1.63M |
| March 31, 2020 | 1.652M |
| December 31, 2019 | 1.748M |
| September 30, 2019 | 1.306M |
| June 30, 2019 | 0.446M |
| March 31, 2019 | 1.583M |
| Date | Value |
|---|---|
| December 31, 2018 | 3.327M |
| September 30, 2018 | 4.563M |
| June 30, 2018 | 4.458M |
| March 31, 2018 | 3.286M |
| December 31, 2017 | 3.366M |
| September 30, 2017 | 3.488M |
| June 30, 2017 | 4.208M |
| March 31, 2017 | 4.504M |
| December 31, 2016 | 5.317M |
| September 30, 2016 | 4.88M |
| June 30, 2016 | 5.794M |
| March 31, 2016 | 5.586M |
| December 31, 2015 | 5.773M |
| September 30, 2015 | 5.848M |
| June 30, 2015 | 5.858M |
| March 31, 2015 | 5.764M |
| December 31, 2014 | 4.757M |
| September 30, 2014 | 13.24M |
| June 30, 2014 | 4.669M |
| March 31, 2014 | 3.374M |
| December 31, 2013 | 3.54M |
| September 30, 2013 | 3.558M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.478M
Minimum
Sep 2020
23.62M
Maximum
Dec 2022
8.194M
Average
7.102M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
| Cytokinetics Inc | -- |
| Scholar Rock Holding Corp | 42.37M |
| Mirum Pharmaceuticals Inc | 32.67M |
| SpringWorks Therapeutics Inc | 44.36M |
| NeuroBo Pharmaceuticals Inc | 8.074M |